Drug
Mgc026 Dose Escalation
Mgc026 Dose Escalation: highest development phase Phase 1, developed by MacroGenics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- MacroGenics
Trials
| Drug | Phase | Indication |
|---|---|---|
| MGC026 Dose Escalation NCT06242470 | Phase 1 | Advanced Solid Tumor |
Latest
No recent events.
Follow Mgc026 Dose Escalation on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.